Tot Biopharm
Chinese Oncology Drug Developer Tot Biopharm Raises $75.2m In HK IPO
Business - Published date: .
Tot Biopharm, a Chinese clinical-stage biopharma firm specialized in innovative oncology drugs and therapies, has raise... Read more
Anti-tumour Drug Developer Tot Biopharm Files For Hong Kong IPO
Business - Published date: .
Tot Biopharm, a Suzhou-headquartered biotechnology firm backed by Chengwei Capital, has filed to list in Hong Kong unde... Read more
Anti-tumour Drug Developer Tot Biopharm Files For Hong Kong IPO
Business - Published date: .
Tot Biopharm, a Suzhou-headquartered biotechnology firm backed by Chengwei Capital, has filed to list in Hong Kong unde... Read more